Invitae Opens Genetic Testing to Adults With ALS Symptoms or Family Risk

Invitae Opens Genetic Testing to Adults With ALS Symptoms or Family Risk

291513

Invitae Opens Genetic Testing to Adults With ALS Symptoms or Family Risk

People at risk or suspected of having some of the most common neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), may now access a genetic test at no charge that could diagnose the condition, and open the way to treatment.  Launched by Invitae, the Adult Neurodegenerative Disorders Sponsored testing program is available to eligible individuals, ages 18 and older, in the U.S., Canada, Australia, and Brazil. The program is the latest of the company’s efforts to…

You must be logged in to read/download the full post.